Polyvinylpyrrolidone-Coated Cubic Hollow Nanocages of PdPt<sub>3</sub> and PdIr<sub>3</sub> as Highly Efficient Self-Cascade Uricase/Peroxidase Mimics.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38391135.
- Also identified by DOI 10.1021/acs.nanolett.4c00071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Uricase-catalyzed uric acid (UA) degradation has been applied for hyperuricemia therapy, but this medication is limited by H<sub>2</sub>O<sub>2</sub> accumulation, which can cause oxidative stress of cells, resulting in many other health issues. Herein, we report a robust cubic hollow nanocage (HNC) system based on polyvinylpyrrolidone-coated PdPt<sub>3</sub> and PdIr<sub>3</sub> to serve as highly efficient self-cascade uricase/peroxidase mimics to achieve the desired dual catalysis for both UA degradation and H<sub>2</sub>O<sub>2</sub> elimination. These HNCs have hollow cubic shape with average wall thickness of 1.5 nm, providing desired synergy to enhance catalyst's activity and stability. Density functional theory calculations suggest the PdIr<sub>3</sub> HNC surface tend to promote OH*/O* desorption for better peroxidase-like catalysis, while the PdPt<sub>3</sub> HNC surface accelerates the UA oxidation by facilitating O<sub>2</sub>-to-H<sub>2</sub>O<sub>2</sub> conversion. The dual catalysis power demonstrated by these HNCs in cell studies suggests their great potential as a new type of nanozyme for treating hyperuricemia.
Medical subject headings
- Peroxidase
- Hyperuricemia